Our top pick for
Eldorado Resorts, Inc is a resorts & casinos business based in the US. Eldorado Resorts shares (ERI) are listed on the NASDAQ and all prices are listed in US Dollars. Eldorado Resorts employs 15,500 staff and has a trailing 12-month revenue of around USD$1.9 billion.
|52-week range||USD$6.02 - USD$82.34|
|50-day moving average||USD$75.7649|
|200-day moving average||USD$57.268|
|Wall St. target price||USD$50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.201|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Eldorado Resorts stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Eldorado Resorts's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Eldorado Resorts's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Eldorado Resorts shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Eldorado Resorts's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$421.6 million.
The EBITDA is a measure of a Eldorado Resorts's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.9 billion|
|Operating margin TTM||11.59%|
|Gross profit TTM||USD$1.3 billion|
|Return on assets TTM||2.2%|
|Return on equity TTM||0%|
|Market capitalisation||USD$3.8 billion|
TTM: trailing 12 months
There are currently 31.7 million Eldorado Resorts shares held short by investors – that's known as Eldorado Resorts's "short interest". This figure is 20.7% up from 26.3 million last month.
There are a few different ways that this level of interest in shorting Eldorado Resorts shares can be evaluated.
Eldorado Resorts's "short interest ratio" (SIR) is the quantity of Eldorado Resorts shares currently shorted divided by the average quantity of Eldorado Resorts shares traded daily (recently around 15.4 million). Eldorado Resorts's SIR currently stands at 2.06. In other words for every 100,000 Eldorado Resorts shares traded daily on the market, roughly 2060 shares are currently held short.
However Eldorado Resorts's short interest can also be evaluated against the total number of Eldorado Resorts shares, or, against the total number of tradable Eldorado Resorts shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eldorado Resorts's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Eldorado Resorts shares in existence, roughly 110 shares are currently held short) or 0.1385% of the tradable shares (for every 100,000 tradable Eldorado Resorts shares, roughly 139 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Eldorado Resorts.
Find out more about how you can short Eldorado Resorts stock.
We're not expecting Eldorado Resorts to pay a dividend over the next 12 months.
Eldorado Resorts's shares were split on a 10:1 basis on 21 August 2012. So if you had owned 1 share the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Eldorado Resorts shares – just the quantity. However, indirectly, the new 90% lower share price could have impacted the market appetite for Eldorado Resorts shares which in turn could have impacted Eldorado Resorts's share price.
Over the last 12 months, Eldorado Resorts's shares have ranged in value from as little as $6.02 up to $82.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eldorado Resorts's is 2.7899. This would suggest that Eldorado Resorts's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Caesars Entertainment, Inc. operates as a casino-entertainment company in the United States. The company operates resorts primarily under the Caesars, Harrah's, Horseshoe, and Eldorado brand names. It offers various amenities and one-of-a-kind destinations; and gaming services. The company was founded in 1937 and is based in Reno, Nevada.
Everything we know about the Reddit IPO, plus information on how to buy in.
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
Everything we know about the Procore IPO, plus information on how to buy in.
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Bukalapak IPO, plus information on how to buy in.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.